Report Type: Therapy Reports
Report Category: Dermatology
Report Subcategory: Androgenic Alopecia
Price: 2999.00
Date: December 2021

Androgenic Alopecia: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Androgenic Alopecia
Androgenetic alopecia is a common form of hair loss in both men and women, caused by a variety of factors tied to the actions of hormones, including some ovarian cysts, taking high androgen index birth control pills, pregnancy, and menopause.

Top 10 Companies:
Johnson & Johnson
Merck & Co Inc
GlaxoSmithKline Plc
Taisho Pharmaceutical Holdings Co Ltd
Almirall SA
Histogen Inc
Puretech Health Plc
Aclaris Therapeutics Inc
BiologicsMD Inc
Moogene Medi Inc